In today’s recent session, 1.15 million shares of the Citius Oncology Inc (NASDAQ:CTOR) have been traded, and its beta is 0.01. Most recently the company’s share price was $1.28, and it changed around -$0.11 or -8.10% from the last close, which brings the market valuation of the company to $91.40M. CTOR at last check was trading at a discount to its 52-week high of $49.00, offering almost -3728.12% off that amount. The share price’s 52-week low was $0.55, which indicates that the recent value has risen by an impressive 57.03% since then.

Citius Oncology Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended CTOR as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.

Citius Oncology Inc (NASDAQ:CTOR) trade information

Instantly CTOR has been showing red trend so far today with a performance of -8.10% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.5200 on recent trading dayincreased the stock’s daily price by 15.79%. The company’s shares are currently up 11.08% year-to-date, but still down -0.20% over the last five days. On the other hand, Citius Oncology Inc (NASDAQ:CTOR) is 41.32% up in the 30-day period.

CTOR Dividends

Citius Oncology Inc’s next quarterly earnings report is expected to be released in July.